HSBC Holdings’s Astera Labs ALAB Stock Holding History

HSBC Holdings’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Buy	+4,600	New	+$1.22M	﹤0.01%	1543

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HSBC Holdings's ALAB Position: Q2 2026 in Review

HSBC Holdings reduced its Astera Labs (ALAB) stake by 26% in Q2 2026, selling an estimated $12.7M and leaving 133,371 shares worth $64.6M. The position accounts for 0.03% of the portfolio, ranked #485.

HSBC Holdings first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

HSBC Holdings held 133,371 shares of Astera Labs worth $64.6M as of Q2 2026.
HSBC Holdings sold 47,926 Astera Labs shares in Q2 2026, an estimated $12.7M.
Astera Labs made up 0.03% of HSBC Holdings's portfolio in Q2 2026, its #485 holding.
HSBC Holdings first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.